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ABSTRACT
Objective: In this study, we describe a novel bioreactor system to deliver controlled stretch protocols
to bioengineered heart muscle (BEHM) constructs. Our primary objective was to evaluate the effect
of mechanical stretch on the contractile properties of three-dimensional cardiac constructs in vitro.
Methods: BEHMs were formed by culturing primary neonatal cardiac myocytes in a fibrin gel using
a method previously developed in our laboratory. A custom bioreactor system was designed using
SolidWorks (Concord, MA) and structural components were manufactured using fusion deposition
modeling. We utilized the bioreactor to evaluate the effect of 2-, 6-, and 24-hour stretch protocols on the
stretch-induced changes in contractile function of BEHMs. Results: We were able to demonstrate
compatibility of the bioreactor system with BEHMs and were able to stretch all the constructs with zero
incidence of failure. We found that loading the constructs for 2, 6, and 24 hours during a 24-hour period
using a stretch protocol of 1Hz, 10% stretch did not result in any significant change in the active force,
specific force, pacing characteristics, and morphological features. Conclusions: In this study, we dem-
onstrate compatibility of a novel bioreactor system with BEHMs and the stability of the BEHMs in
response to stretch protocols.
INTRODUCTION
RESEARCH IN THE FIELD OF cardiac tissue engineeringis focused on the development of functional three-
dimensional heart muscle in vitro. Conceptually, autologous
patient-derived stem cells can be differentiated to a cardiac
origin and utilized to engineer functional three-dimensional
heart muscle. Heart muscle that has been engineered in vitro
can be utilized clinically to treat cases of acute myocardial
infarction. In addition, functional heart muscle would prove
to be a valuable model for basic cardiology research and to
evaluate the efficacy and safety of potential cardio-active
drugs.
Several strategies have been described to promote the
formation of three-dimensional heart muscle. Eschenhagen
et al. utilized a collagen matrix to promote the culture of
chick cardiac myocytes resulting in the formation of func-
tional three-dimensional heart muscle.1 The initial model
was refined by casting a mixture of neonatal cardiac myo-
cytes and collagen into plastic molds to generate engineered
heart tissue.2 Carrier et al. utilized fibrous meshes made
from polyglycolic acid as a scaffolding material for cultur-
ing neonatal cardiac myocytes.3 Okano and coworkers uti-
lized temperature-sensitive polymer surfaces to engineer
three-dimensional cardiac tissue.4,5 Akins et al. utilized a
rotating bioreactor system to promote the organization of
isolated cardiac cells on the surface of microcarrier beads.6
Collectively, the work supports the ability of primary car-
diac myocytes to form tissue-engineered heart muscle under
controlled in vitro conditions.
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We have previously developed a method to engineer func-
tional three-dimensional skeletal7–9 (myooids) and cardiac10
(cardioids) muscles in vitro. In addition, we have recently
extended our cardioid model and shown the utility of using
fibrin gel to support the formation of bioengineered heart
muscle (BEHM).11 During BEHM formation, primary car-
diac myocytes are isolated from neonatal rat hearts and
plated on the surface of a tissue culture plate coated with
fibrin. Spontaneous contractions of the primary cardiac
myocytes result in compaction of the fibrin gel promoting
BEHM formation. BEHMs are 12mm long and have a di-
ameter of 200–250 mm. BEHMs have been shown to gen-
erate an active force of 300–500 mN and a specific force of
12–15KN/m2, and can be electrically paced at frequencies
1–7Hz. In addition, BEHMs are responsive to external
calcium and cardio-active drugs like isoproterenol and epi-
nephrine, and express several cardiac-specific proteins
(collagen type I, F-actin, connexin43, and N-cadherin).11
Our current research is focused on defining culture condi-
tions to promote the phenotypic maturation of BEHMs in
the form of chemical, electrical, and mechanical stimulation.
To this end, we have developed a new bioreactor system to
allow application of coordinated electromechanical stretch
to BEHMs during culture. Our bioreactor system is designed
to permit coordinated, simultaneous electrical andmechanical
stimulation of the BEHMs in culture. The stimulation proto-
cols can be carried out using automated stimulation algo-
rithms embedded in the onboard microprocessors of each
bioreactor for long periods of time (weeks or months) while
permitting the culture media to be changed manually, as
would occur in traditional cell culture using Petri dishes.
There have been a few studies evaluating the effect of
mechanical loading on tissue-engineered heart muscle.12,13
Akhyari et al. showed that a 20% strain at a frequency of
1.33Hz for a period of 14 days resulted in an increase in cell
proliferation and uniform cell distribution throughout the
construct.12 Fink et al. showed that a stretch protocol of 20%
strain at 1.5 Hz frequency for 6 days resulted in doubling of
the active force of their cardiac constructs.13
Although there have been studies showing the effect of
mechanical stretch on the functional performance of tissue-
engineered heart muscle, there has been a lack of adequate
instrumentation to control the stimulation protocol thereby
permitting variable tissue responses allowing detailed un-
derstanding of the underlying mechanism. The system de-
veloped by Fink et al. allowed a single frequency of 1.5Hz
to be tested, whereas the system developed by Akhyari et al.
failed to correlate the stretch to contractile performance. We
believe that there is a strong need to develop accurate instru-
mentation to carefully control tissue-stimulation parameters
and correlate the degree of stretch to changes in contractile
performance. To accommodate the need for instrumentation,
the purpose of this study was to evaluate the feasibility of
utilizing the current bioreactor to support the viability of
BEHMs and to evaluate subsequent changes in contractile
performance.
MATERIALS AND METHODS
Approval for animal use was granted by the University
Committee for the Use and Care of Animals (UCUCA)
in accordance with the ‘‘Guide for the Care and Use of La-
boratory Animals’’ (NIH publication 86-23, 1986). All ma-
terials were purchased from Sigma (St. Louis, MO) unless
otherwise specified.
Bioreactor system
The mechanical components of the bioreactor system are
shown schematically in Figure 1. The system was designed
using SolidWorks solid modeling and design software (Solid
Works, Concord, MA). Individual structural components
were rapid manufactured using a Titan model T1 fusion de-
position modeling (FDM) machine (StrataSys, Minneapolis,
MN). The individual structural components of the bioreac-
tor were first designed in SolidWorks, mechanical assembly
and fit was verified in solid assembly drawings, and then
FIG. 1. Bioreactor design. (A) Primary structural components for
the bioreactors were rapid manufactured from FDA-compliant
polycarbonate thermoplastic using a StrataSys Titan T1 fusion de-
position modeler. (B) An exploded view of the assembly. Each
bioreactor also included standard commercially available off-the-
shelf (COTS) components, including a gearhead stepper motor
(MicroMo), an ACME power screw and low-friction nut, and stain-
less steel type 18-8 threaded fasteners (not shown). The modifi-
cations to the COTS components were very minimal, typically
limited to simple processes such as cutting stainless steel tubing to
the desired length. The authors will freely provide the solid model
files and a list of other components to interested researchers upon
request.
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individual component files were converted to *.STL format
and were rapid manufactured from U.S. Food and Drug
Administration (FDA)–compliant polycarbonate (PC-10)
material on the FDM. This process allowed both rapid de-
velopment time and rapid manufacture of several bioreactor
units for use in this study. Metal fasteners and mechanism
components were purchased as commercially available off-
the-shelf (COTS) mechanism components from McMaster-
Carr Supply (Cleveland, OH). The system was controlled
by a low-cost, small form factor (*35 cm) stepper motor
driver circuit specifically designed for this application
(Fig. 2). The stepper controller circuit also allowed for direct
user interface and control of each bioreactor, both for system
set-up and to initiate the experimental protocol. The actual
mechanical strain protocol was programmed directly onto
the embedded microcontroller prior to each experiment, and
was not adjustable by the user during the course of each
experiment. An identical circuit can be employed to provide
two channels of bipolar square-wave electrical stimulation
to the tissues in culture, allowing the muscle to be activated
at a known time with respect to the application of mechan-
ical strain.
General description of the system
Each bioreactor can be loaded with up to 11 separate
35mm culture dishes, each containing a single tissue con-
struct, in this case BEHMs. The bioreactor systems are de-
signed to readily accommodate a range of self-organizing
tissues, including skeletal, cardiac, and smooth muscles, ten-
don and ligament, and bone. Adjacent to each 35mm plate
is a movable post. One end of each tissue specimen is affixed
to this post via a stainless steel wire that is shaped to allow it
to pass under the cover of the 35mm dish and attach to the
stainless steel minutien pins that affix the ends of each tis-
sue specimen. The 35mm plates do not require modifica-
tion; the lids are simply tipped forward to accommodate the
stainless steel wire. The culture plates are held stationary
above a moving platform to which the movable posts are
affixed below. Thus, during mechanical movement of the
posts, the tissue specimen length is changed but the base of
the culture dish remains motionless. This arrangement
minimizes sloshing of the culture media that would occur
if the culture dish was moved cyclically or dimensionally
deformed.
FIG. 2. Schematic diagrams for the stepper motor driver and controller. Small (35 cm), low-cost stepper motor drivers were
designed and manufactured using printed circuit boards designed with free software (ExpressPCB) and ordered online from ExpressPCB
(www.expresspcb.com/). The embedded microcontroller (PIC16F84A) was programmed using a PIC-C compiler (CCS, Brookfield, WI)
to simply energize the coils as indicated on the schematic at preselected time intervals to achieve displacement, direction, and strain-rate
control for applying mechanical strain to the tissue specimens. Four bits (input registers RB4–RB7) were used to control each system by
detecting the state of four momentary-ON push buttons. The four commands were (i) <HOME>, which sends linear slide to the HOME
position for setup; (ii) <SHORTEN> and (iii) <LENGTHEN>, which allow manual control of the linear slide in each direction; and
(iv) <RUN>, which executes the strain protocol continuously until another command is received.
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The mechanical strain mechanism is comprised of a lin-
ear actuator that drives the moving platform beneath the
culture plates. The linear actuator is a direct-drive ACME
miniature power screw (ACME diameter 0.216@, 4 starts, 5.2
revolutions/inch, McMaster-Carr, catalog # 6642K16) af-
fixed to the output shaft of the gearhead stepper motor.
Mechanical strain of the same amplitude is applied to all
specimens simultaneously. In general, different mechanical
stimulus protocols would be carried out on separate but
identical bioreactors. Mechanical strain is controlled by a
gearhead stepper motor (MicroMo Electronics, Clearwater,
FL), which is driven by an open-loop stepper motor driver
shown in Figure 2. The stepper motor driver is a modified
version of an implantable muscle stimulator used by our
laboratory, which was reported earlier.14
For each mechanical strain cycle, the stepper motor driver
starts at a HOME position defined mechanically by the po-
sition of an optical interrupter (Panasonic # ON1111 Photo
Interrupter; Matsushita Electric Industrial, Osaka, Japan),
which provides a single-bit digital signal to the motor driver
circuit. The stepper motor driver then drives the strain mech-
anism at the desired rate in the desired direction for the pre-
programmed length of each strain application, after which
themechanism returns to theHOMEposition. By this means,
cycle-to-cycle mechanical drift is eliminated without the
need to employ sophisticated closed-loop control. At the end
of the system design and fabrication phase, the system was
tested for 3weeks with continuous cyclic strain, with no
detectable drift from the original strain parameters.
Isolation of neonatal cardiac myocytes
Cardiac myocytes were isolated from the hearts of 2- to
3-day-old F344 rats using an established method.15 Briefly,
hearts were cut into fine pieces and suspended in a disso-
ciation solution that consisted of 0.32mg/mL collagenase
type II (Worthington Biochemical, Lakewood, NJ) and
0.6mg/mL pancreatin dissolved in a buffer consisting of
116mM sodium chloride (NaCl), 20mM HEPES, 1mM
disodium phosphate (Na2HPO4), 5.5mM glucose, 5.4mM
potassium chloride (KCl), and 0.8mM magnesium sulfate
(MgSO4). Serial digestionwas carried out in an orbital shaker
for 5minutes at 378C, and the supernatant was collected in
5mL of horse serum (Invitrogen, Auckland, New Zealand).
Cells from all the digests were pooled, centrifuged, and then
suspended in culture medium (CM) consisting of 320mL
M199, 100mL F12K, 50mL fetal bovine serum, 25mL
horse serum, 5mL antibiotic–antimycotic, 40 ng/mL hydro-
cortisone, and 40 mg/mL ascorbic acid (Invitrogen). The final
cell concentration was adjusted to 1106 cells/mL.
Preparation of the plates
The method for preparing the culture surface for engineer-
ing skeletalmuscle has been described in detail previously.7,16
This procedure was modified to engineer cardiac muscle.10
Briefly, 35mm culture plates were coated with 1.5mL of
a polydimethylsiloxane (PDMS) elastomer (Dow Chemical,
Midland, MI). Anchor points were 6-mm-long segments of
size 0 braided silk sutures (Ethicon, Cornelia, GA) pinned
12mm apart in the center of the culture surface (Fig. 3).
Formation of fibrin gel and cell plating
To promote gel formation, 0.5mL of CM containing
10U/mL thrombin was plated on the surface of 35mm cell
culture plates coated with Sylgard (PDMS, type 184 sili-
cone elastomer). After this, 200 mL of 20mg/mL fibrinogen
was added to the 35mm plate. The solution was mixed to
promote the formation of a fibrin gel within 10–15minutes.
Primary cardiac cells were diluted in CM at 1 million cells/
mL and plated in 1mL of CM for each plate after complete
gel formation.
The cells were cultured in an incubator at 378C and 5%
carbon dioxide with medium changes everyday. All culture
plates were maintained for 2weeks until most fibrin was de-
graded, and then the mechanical-loading group was placed
into the bioreactor for another 7 days. The control group was
still in static culture for another 7 days.
Placement of BEHMs onto the bioreactor
The BEHMs were cultured in individual 35mm culture
plates until the self-organization of the BEHM was com-
plete. After BEHM formation, the entire culture plate for
each specimen was loaded onto a bioreactor as described
above (Fig. 4A). First, the 35mm plate was placed into a
well in the bioreactor, and then an L-shaped arm composed
of a stainless steel stick with L-shaped silicone tube at one
end was affixed to the bioreactor. The silicone tube was kept
inside the 35mm plate (Fig. 4B). One stainless steel pin at
the end closer to the L-shaped arm was released while an-
other pin was connected to the silicone part by lifting the pin
from the sylgard surface (Fig. 4C).
Electromechanical stimulation protocol
For our first series of experiments, we loaded the fibrin gel
constructs onto the bioreactor and stimulated for 2 hours per
day, 6 hours per day, and 24 hours for 7 days at a frequency
of 1Hz with 10% stretch. Controls were maintained in static
cell culture for the 7-day period. For all studies (except the 2-
hour loading protocol), the active force of the BEHMs was
evaluated before and after the 7-day loading protocol.
Evaluation of contractility
The method for evaluating the contractility of engineered
skeletal muscle has been described in detail elsewhere.7 The
method was modified to test engineered cardiac tissue.
Briefly, the BEHMs were stimulated between parallel plat-
inum electrodes, and the active force was measured using a
custom-built optical force transducer.7 An electrical impulse
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FIG. 3. Description of bioengineered heart muscles (BEHMs). (A) Methodology for construct formation: neonatal cardiac myocytes
are mixed with fibrinogen and then thrombin. The cell suspension is then plated on the polydimethylsiloxane surface. The spontaneous
contractility of the neonatal cardiac myocytes resulted in delamination of the cell monolayer. (B–D) Stages of BEHM formation:
delamination initiated at the (B) periphery of the culture surface and progresses toward the (C) center of the culture surface. (D) After
complete formation, the BEHM remained suspended between anchor points that have been pinned to the culture surface with 0.1mm
pins. Color images available online at www.liebertpub.com/ten.
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of 15V with a pulse width of 10ms and a frequency of 1Hz
was used. The active force was measured using a custom-
made optical force transducer, and force tracings were
digitally recorded using LabVIEW (National Instruments,
Austin, TX). The active force was normalized to the total
cross-sectional area of the BEHM to obtain the specific force.
The cross-sectional area of the BEHMs was calculated from
the construct diameter, whichwas determined by a calibrated
eyepiece reticle with a resolution of 5 mm.
Histology
BEHMs were fixed in a 4% paraformaldehyde solution for
4 hours, rinsed in 70% ethanol, and stored in 70% ethanol
until use. The BEHMs were prepared using a graded ethanol
process with an automated tissue processor (Shandon Hy-
percenter XP; Thermo Electron, Waltham, MA) for 7 hours
and 36minutes. The BEHMs were then paraffin embedded.
The paraffin-embedded samples were sectioned at 7 mm on
a microtome processor and placed on ProbeOn Plus slides
(Fisher Scientific, Pittsburgh, PA) for histology.Hematoxylin-
and-eosin staining was used for morphologic analysis. Sec-
tions were viewed and photographed using a Nikon Axiophot
inverted phase contrast microscope.
Statistical analysis
We used one-way analysis of variance (ANOVA) for all
pair-wise comparisons. Minitab V13.31 (State College, PA)
was used for statistical analysis with p< 0.05.
RESULTS
Each bioreactor allowed up to 11 individual tissue spec-
imens to be subjected as a group to the same mechanical
stimulation protocol. Rapid manufacturing of the bioreactor
systems using cell culture incubator tolerant materials as
well as the use of standard cell culture disposable plastic
in the bioreactor system design provided several significant
advantages. Designs could be rapidly and inexpensively
implemented, and design changes were readily made. Com-
ponent interchangeability was maintained, and it was in-
expensive to expand the capability to process fairly large
numbers of tissue specimens simultaneously by simply rapid
manufacturing additional bioreactor systems to meet the
experimental need.
The design of the bioreactor proved suitable for trans-
forming the static-engineered muscle culture for dynamic
mechanical-loading studies without physical transfer of the
construct. We were able to use the culture methodology de-
veloped in our laboratory and then place the 35mm plates
into the bioreactor for different mechanical-loading studies.
In addition, using the microchip in the bioreactor, we were
able to reprogram the training protocols fairly easily.
FIG. 4. The setup of the bioreactor for the cardiac constructs.
(A) The overview of eleven 35mm culture plates placed in the
bioreactor. CP: control panel, MR: metal rod, SP: stationary plat-
form, M: motor, CB: circuit board. (B) A close picture showing
the connection between the bioreactor and bioengineered heart
muscle (BEHM). One end of the BEHM had been lifted and con-
nected to the steel arm through the steel pin and silicon tube.
(C) Schematic showing the BEHM attachment to the bioreactor
arm. AB: steel arm, AP: plastic support, C: construct, CP: culture
plate, MP: 1mm steel pin, SS: silk suture, ST: silicon tube. Color
images available online at www.liebertpub.com/ten.
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FIG. 5. Effect of controlled stretch on the active force of bioengineered heart muscles (BEHMs). BEHMs were placed in the
bioreactor and subjected to a 10% stretch for 2, 6, and 24 hours per day for 7 days at a frequency of 1Hz. The maximum active force and
the pacing characteristics of the BEHMs were evaluated after 7 days. (A) Representative force tracing of BEHMs in response to loading
when stretched for 2 hours per day. (B) Pacing of the mechanically loaded BEHMs after a 2-hour loading protocol. There was no
difference in the maximum active force of the BEHMs in response to loading protocols for (C) 2, (D) 6, and (F) 24 hours per day when
compared to controls. Changes in the active force of individual BEHMs are displayed for the (E) 6-hour and (G) 24-hour loading
protocol. The active force obtained after the loading protocol is normalized to the active force of the BEHM prior to starting the loading
protocol. There was no statistically significant change in the active force or the specific force of the BEHMs in response to mechanical
loading for the 2-, 4-, and 24-hour loading protocol.
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Our methodology for the formation of tissue-engineered
constructs was easily reproducible. We engineered a total of
62 constructs for this study with zero incidence of failure for
the controls, as evaluated by the ability of the isolated cells
to remodel to form functional constructs. The mean active
force for the controls, evaluated 14 days after initial cell
plating, was found to be 12.1 0.62 kPa (n¼ 31) with a
mean diameter of 207 5.7 mm (n¼ 31).
We were able to validate compatibility of the bioreactor
system with our tissue-engineered constructs. During our 7-
day stretch protocol, there was no significant change in the
diameter with the mean diameter of the constructs found to
be 212 8.4 mm (n¼ 31). Of the 31 constructs that we tested
in our bioreactor, we had 2 cases of failure, after being
subjected to a stretch protocol of 6 hours loading during 24-
hour time points for 7 days. The maximum specific force of
both constructs was in excess of the mean value of 12.1 kPa
prior to the loading protocol. There were no visible signs of
construct damage and/or physical tearing of the two con-
structs. There was however a significant decrease in the di-
ameter of these two constructs during the 7-day loading
protocol, from 200 to 50 mm for one construct and from 220
to 150 mm for the second construct.
Our studies were designed to evaluate the stability of the
BEHMs in response to mechanical stretch and we therefore
selected mild loading conditions (Fig. 5). We found that
there was no apparent physical damage of the BEHMs in
response to varying stretch times of 2, 6, and 24 hours per
24-hour time period (Fig. 5A). We also found that there was
no decline in the active force in response to these stretch
protocols (Fig. 5C, D, F). The mean active force and the
mean specific force of the constructs followed the same trend,
as there was no significant change in construct diameter
during stretch (data not shown). The mean specific force of
BEHMs (both controls and stretched) loaded for 24 hours
was lower than BEHMs stretched for 2 and 6 hours. These
numbers reflect the batch variability in the primary cardiac
cells, which were obtained from different batches for each of
the three runs, rather than a response to the mechanical-
loading protocols. We were also able to electrically pace the
constructs (stretch and controls) after the three loading pro-
tocols (Fig. 5B) at frequencies of 1–7Hz with no differences
between the groups. The normalized active force (post-
stretch active force normalized to prestretch values) of the
stretched BEHMs followed the same trend as the normalized
active force for control BEHMs (Fig. 5E, G).
We evaluated the morphological characteristics of the
constructs in response to the 6-hour cyclic loading protocol
(Fig. 6). There was no physical damage to the constructs in
response to the cyclic loading protocols. We found that the
diameter of the constructs did not change significantly after
the loading protocol and was in the order of 200–250 mm for
both groups. There were a large number of well-aligned cells
present throughout the thickness of the construct. In addi-
tion, we found large amounts of undegraded fibrin (which
stains pink) in both groups with minimal damage to the
fibers themselves. Our preliminary results showed a higher
degree of undegraded fibrin in the mechanically stretched
BEHMs (Fig. 6). These preliminary studies showed the
compatibility of the bioreactor system with BEHMs as well
as structural stability of the constructs in response to stretch
protocols.
DISCUSSION
Our previous studies have been focused on defining con-
ditions that promote the remodeling of isolated primary car-
diac cells to form functional heart muscle under controlled
in vitro cell culture conditions. Using our current method-
ology, we have been able to engineer three-dimensional
heart muscle that exhibits several physiological metrics of
cardiac function.11 We have shown that the constructs gen-
erate active force upon electrical stimulation, can be electri-
FIG. 6. Histological evaluation of constructs after cyclic load-
ing. Hematoxylin-and-eosin staining was used to evaluate the
morphological characteristics of the bioengineered heart muscles
(BEHMs). (A) Control and (B) BEHMs after stretch. For these
particular images, the BEHMs were stretched in the bioreactor
for 6 hours every 24 hours for 7 days at a frequency of 1Hz. Scale
bars represent 50 mm. Color images available online at www
.liebertpub.com/ten.
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cally paced, show characteristics length–force and calcium
sensitivity curves, and are responsive to cardio-active drugs.
As we explore new ways to match the functional perfor-
mance of our constructs to that of native cardiac muscle, we
seek to explore the effects of mechanical stimulation on the
functional outcome of the constructs. This particular study
was designed to develop a bioreactor system to study the
effect of controlled mechanical loading on the functional
performance of three-dimensional heart muscle.
One of the critical technological hurdles in delivering con-
trolled mechanical loading to tissue-engineered constructs is
the lack of cell culture instrumentation. Commercially avail-
able systems are sparse and often not compatible with three-
dimensional constructs. Therefore, we sought to develop our
own system to deliver controlled mechanical-loading proto-
cols to our heart muscle constructs. The systemwe describe in
this report was developed to be compatible with many of the
self-organizing functional mammalian tissue constructs we
have reported earlier, such as cardiac,17,18 skeletal,7,9,16,19 and
smooth muscles,20 in addition to tendon and ligament,21 as
well as recellularized peripheral nerve.22,23 The use of rapid
manufacturing technology, local embedded control, standard
disposable polystyrene cell culture Petri dishes, and inter-
changeable standard mechanical drive components enables
the reconfiguration of each system to accommodate the tis-
sues being studied in each case. The architecture of the sys-
tem also allows the addition of expanded functionality, such
as the addition of electrical stimulators for the tissues, the
use of different-sized culture dishes, or the addition of force
transducers to monitor the mechanical stiffness or active con-
tractility of the engineered tissues. For this first study, only
mechanical strain was applied.
Our experiments were designed to evaluate the compati-
bility of the bioreactors with our cardiac constructs, BEHMs.
One of the challenges was to load the constructs onto the
bioreactor platform without any physical damage to the
constructs. Physical transfer of the constructs from the cul-
ture vessel to the bioreactor was eliminated by fabricating
individual slots to allow placement of the entire culture
vessel onto the bioreactor platform. Utilizing this method-
ology, we were able to load the constructs onto the biore-
actor under sterile conditions without any physical damage.
Our second challenge was to apply controlled strain with-
out physical damage to the BEHMs, either at the muscle–
suture interface or within the construct itself. We decided to
load theBEHMs in a stepwisemanner, startingwith a loading
protocol consisting of 2 hour of 10% stretch at 1Hz per day
for a period of 7 days. We found that there was no physical
damage (evaluated by specific force) to the BEHMswith this
relatively mild loading protocol and incrementally increased
the time to 6 hours and subsequently 24 hours per day for
7 days. Of the 33 constructs that we subjected to loading
protocol, only 2 constructs failed. There was a significant
decrease in the diameter of these two BEHMs, indicative of
rapid fibrin degradation thereby limiting functional remod-
eling. We have observed this behavior before and believe
that the failure is a physiological response rather than a
mechanical failure due to the loading protocol.
Histological evaluation supported structural integrity of
the BEHMs in response to loading protocols. There ap-
peared to be a greater fibrin content of the BEHMs subjected
to the stretch protocols. In addition, we also found similar
results for collagen type I, as determined by Mason’s tri-
chrone staining (data not shown), greater abundance of
aligned collagen fibers for the BEHMs in response to me-
chanical stretch. We did not conduct a full histological
analysis and can therefore only speculate that the changes in
extracellular matrix are due to the mechanical stretch.
During our initial experiments, we were able to validate
the compatibility of the bioreactor system with our con-
structs using gentle loading protocols. As we gradually in-
creased the loading time from 2 to 24 hours, we found that
there was no increase in contractile performance of the
constructs. Although this was indicative of no mechanical
damage to the constructs, there was some concern about the
lack of functional improvement.
There has been one other study evaluating the effect of
controlled mechanical stretch on the contractile perfor-
mance of tissue-engineered heart muscle.13 A 6-day load-
ing protocol at a frequency of 1.5Hz and a strain of 5%
resulted in a fourfold increase in force generation. The
increase in force production was explained in terms of the
hypertropic response of the cardiac myocytes. In the work
described by Akhyari et al.,12 the contractile performance
was not evaluated; therefore, a comparison to this work
proves difficult. Although we were not able to show an im-
provement in contractile force in response to mechanical
stretch, we do believe that optimization of the stretch pro-
tocol will allow us to see functional improvements.
We believe that this study serves a twofold purpose. First,
we describe a novel bioreactor system, which was rapid
manufactured to create several systems for use in this and
other ongoing studies to deliver controlled cyclic loading to
tissue-engineered constructs. Second, we demonstrate com-
patibility of the bioreactor with our BEHM model.
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